Protective immunity in HIV infection: Where do we stand?

Infection

Volumn 32, Issue 4, 2004, Pages 250-252

  Draenert, R ^a   Goebel, F D ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEF PROTEIN; NEUTRALIZING ANTIBODY; VIRUS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN PRESENTATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MONKEY DISEASE; NONHUMAN; PROTEIN TARGETING; SHORT SURVEY; SUPERINFECTION; T LYMPHOCYTE; VIRUS MUTATION; VIRUS TRANSMISSION; ANTIBODY PRODUCTION; CD4+ T LYMPHOCYTE; IMMUNOLOGY; REVIEW;

AIDS VACCINES; ANTIBODY FORMATION; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; HIV INFECTIONS; HUMANS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 4444224962     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (10)

1. Ramos A, D.J. Hu L, Nguyen K.O et al.: Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J Virol 2002; 76: 7444-7452.
2. Jost S, Bernard MC, Kaiser L et al.: A patient with HIV-1 superinfection. N Engl J Med 2002; 347: 731-736.
3. Altfeld M, Allen TM, Yu XG et al.: HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 2002; 420: 434-439.
4. Goulder PJ, Brander C, Tang Y et al.: Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 2002; 412: 334-338.
5. Leslie AJ, Pfafferott KJ, Chetty P et al.: HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 2004; 10: 282-289.
6. Friedrich TC, Dodds EJ, Yant LJ et al.: Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat Med 204; 10: 275-281.
7. Draenert R, Le Gall S, Pfafferott KJ et al.: Immune Selection for Altered Antigen Processing Leads to Cytotoxic T Lymphocyte Escape in Chronic HIV-1 Infection. J Exp Med 2004; 199: 905-915.
8. Kaufmann DE, Bailey PM, Sidney J et al.: Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J Virol 2004; 78: 4463-4477.
9. Lu W, Wu X, Lu Y et al.: Therapeutic dendritic-cell vaccine for simian AIDS. Nat Med 2003; 9: 27-32.
10. Richman DD, Wrin T, Little SJ et al.: 2003. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci U S A 2003; 100: 4144-4149.